These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 7477618)

  • 21. Tophaceous gout in patients with renal transplants treated with cyclosporine A.
    Baethge BA; Work J; Landreneau MD; McDonald JC
    J Rheumatol; 1993 Apr; 20(4):718-20. PubMed ID: 8496871
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hypouricemia due to renal tubular defect. A study with the probenecid-pyrazinamide test.
    Smetana SS; Bar-Khayim Y
    Arch Intern Med; 1985 Jul; 145(7):1200-3. PubMed ID: 4015266
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hyperuricemia in adult renal allograft recipients: prevalence and predictors.
    Malheiro J; Almeida M; Fonseca I; Martins LS; Pedroso S; Dias L; Henriques AC; Cabrita A
    Transplant Proc; 2012 Oct; 44(8):2369-72. PubMed ID: 23026595
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of renal handling of uric acid in essential hypertension: hyperuricemia related to decreased urate secretion.
    Tykarski A
    Nephron; 1991; 59(3):364-8. PubMed ID: 1758523
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacological evaluation of urate renal handling in humans: pyrazinamide test vs combined pyrazinamide and probenecid administration.
    Colussi G; Rombolà G; De Ferrari ME; Rolando P; Surian M; Malberti F; Minetti L
    Nephrol Dial Transplant; 1987; 2(1):10-6. PubMed ID: 3110689
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Renal handling of urate and the incidence of gouty arthritis during cyclosporine and diuretic use.
    Noordzij TC; Leunissen KM; Van Hooff JP
    Transplantation; 1991 Jul; 52(1):64-7. PubMed ID: 1858156
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hypouricemia due to increased tubular secretion of urate in children with Amanita phalloides poisoning.
    Zawadzki J; Jankowska I; Moszczyńska A; Januszewicz P
    Nephron; 1993; 65(3):375-80. PubMed ID: 8289987
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Renal handling of urate in two patients with hyperuricemia and primary hyperparathyroidism.
    Hisatome I; Ishimura M; Sasaki N; Yamakawa M; Kosaka H; Tanaka Y; Kouchi T; Mitani Y; Yoshida A; Kotake H
    Intern Med; 1992 Jun; 31(6):807-11. PubMed ID: 1392185
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Natural history and etiology of hyperuricemia following pediatric renal transplantation.
    Edvardsson VO; Kaiser BA; Polinsky MS; Palmer JA; Quien R; Baluarte HJ
    Pediatr Nephrol; 1995 Feb; 9(1):57-60. PubMed ID: 7742224
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The association between serum uric acid levels at 3 months after renal transplantation and the graft outcome in living donor renal transplantation.
    Choi JY; Kwon OJ
    Transplant Proc; 2013 May; 45(4):1548-52. PubMed ID: 23726617
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Uricosuric effect of irtemazole in hyperuricemic patients without and with renal insufficiency.
    Kamilli I; Gresser U; Pellkofer T; Löffler W; Zöllner N
    Z Rheumatol; 1989; 48(6):307-12. PubMed ID: 2623976
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Uricosuric medications for chronic gout.
    Kydd AS; Seth R; Buchbinder R; Edwards CJ; Bombardier C
    Cochrane Database Syst Rev; 2014 Nov; 2014(11):CD010457. PubMed ID: 25392987
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hyperuricosuria and increased tubular secretion of urate in sickle cell anemia.
    Diamond HS; Meisel A; Sharon E; Holden D; Cacatian A
    Am J Med; 1975 Dec; 59(6):796-802. PubMed ID: 1103619
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Uric acid is highly associated with kidney allograft survival in a time-varying analysis.
    Weng SC; Shu KH; Tarng DC; Cheng CH; Chen CH; Yu TM; Chuang YW; Huang ST; Wu MJ
    Transplant Proc; 2014; 46(2):505-10. PubMed ID: 24656000
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Kidney function in cyclosporine-treated pediatric heart transplant recipients.
    Laine J; Jalanko H; Leijala M; Sairanen H; Holmberg C
    J Heart Lung Transplant; 1997 Dec; 16(12):1217-24. PubMed ID: 9436133
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Influence of urate-lowering therapies on renal handling of uric acid.
    Ma L; Wei L; Chen H; Zhang Z; Yu Q; Ji Z; Jiang L
    Clin Rheumatol; 2016 Jan; 35(1):133-41. PubMed ID: 25373449
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The natural history of urate overproduction in sickle cell anemia.
    Diamond HS; Meisel AD; Holden D
    Ann Intern Med; 1979 May; 90(5):752-7. PubMed ID: 434674
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Glomerular and tubular function in renal transplant patients treated with and without ciclosporin A.
    Hansen JM; Fogh-Andersen N; Leyssac PP; Strandgaard S
    Nephron; 1998 Dec; 80(4):450-7. PubMed ID: 9832645
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Renal hypouricemia due to enhanced tubular secretion of urate associated with urolithiasis: successful treatment of urolithiasis by alkalization of urine K+, Na(+)-citrate.
    Hisatome I; Tanaka Y; Kotake H; Kosaka H; Hirata N; Fujimoto Y; Yoshida A; Shigemasa C; Mashiba H; Sato R
    Nephron; 1993; 65(4):578-82. PubMed ID: 8302413
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Diabetic renal hypouricemia.
    Shichiri M; Iwamoto H; Shiigai T
    Arch Intern Med; 1987 Feb; 147(2):225-8. PubMed ID: 3813739
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.